Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
jeudi, octobre 15
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Ginkgo Bioworks Holdings Inc
DNA
NYSE
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$11.53
-0.23
-1.96%
Get Report
Aperçu
Actualités
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Rapport sur les stocks
Privacy Manager
Ginkgo Bioworks Holdings Financials
Ginkgo Bioworks Holdings (DNA) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Ginkgo Bioworks Holdings Q1 EPS $(1.39) Misses $(1.34) Estimate, Sales $19.474M Miss $41.520M Estimate
Benzinga Newsdesk
Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter
Ginkgo Bioworks stock drops after earnings miss, lower sales, and shift to autonomous labs and robotics focus.
Vandana Singh
PRO
Ginkgo Bioworks Holdings Q4 EPS $(1.41) Misses $(1.36) Estimate, Sales $33.318M Miss $37.617M Estimate
Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly losses of $(1.41) per share which missed the analyst consensus estimate of $(1.36) by 3.68 percent. This is a 29.5 percent increase over losses of $(2.00) per share
Benzinga Newsdesk
Earnings Scheduled For February 26, 2026
Benzinga Insights
Insights into Ginkgo Bioworks Holdings's Upcoming Earnings
Benzinga Insights
Ginkgo Bioworks Stock Plummets Following Q3 Estimates Miss, Reaffirms FY2025 Outlook Below Consensus
Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares are trading lower on Friday. The company released its third-quarter financial results.
Evette Mitkov
